The Gout Market forecast projects a healthy growth trajectory, fueled primarily by the anticipated launch and uptake of novel therapeutic agents over the next decade, which will diversify treatment options beyond the established generic ULTs. The expected market expansion will be driven not just by increasing patient volumes but also by a premiumization of the therapeutic landscape as...

Market Overview The Chronic Refractory Gout Market is witnessing steady growth as the prevalence of gout and related comorbidities continues to rise worldwide. Chronic refractory gout is a severe form of gout that does not respond adequately to conventional urate-lowering therapies, resulting in persistent uric acid crystal deposition, joint inflammation, and tophi formation. Patients often...